Year 12 Biology ★ IQ2 Synthesis ⏱ ~35 min Practice bank · 3 Short Answer Lesson 12 of 18

Biotechnology Synthesis, Evaluating Benefit, Risk and Biodiversity

The Target Malaria consortium (Gates Foundation-funded) proposed in 2015 releasing gene-drive-modified Anopheles mosquitoes to suppress malaria vector populations. A 2019 field trial in Burkina Faso was the first African release. WHO 2022 data show 247 million malaria cases that year. Gene drives spread through populations at ~100% rather than ~50% (Mendelian), making them uniquely powerful and uniquely irreversible. IQ2 closes here: apply your full evaluation framework to this case.

Today's hook: The Target Malaria consortium, backed by the Gates Foundation, proposed in 2015 using CRISPR gene drives to suppress Anopheles mosquito populations and reduce malaria transmission. In 2019 they conducted the first African field trial in Burkina Faso. WHO reported 247 million malaria cases in 2022. Gene drives spread at 100% efficiency, not 50%, so once released, they cannot be recalled. What evaluation framework would you use to decide whether this technology should be deployed globally?
0/5TASKS
Worksheets

Practise this lesson

Four printable worksheets that build from the foundations up to exam-style questions, start at whatever level suits you.

Framework for evaluating biotechnology applications

Framework for evaluating biotechnology applications, benefit, risk, stakeholders, biodiversity, qualified conclusion.

Extended Case Entry
warm-up

You are asked: To what extent do genetic techniques benefit society? A weak answer would list a few benefits and stop there.

Write what else a strong answer should include. Try to name at least three categories of judgement beyond simple benefit-listing.

Learning Intentions
goals

Know

  • Strong biotechnology judgements include benefit, risk, biodiversity and stakeholder dimensions.
  • Different case studies can point in different directions.
  • Absolute answers are usually weaker than conditional ones.

Understand

  • Biotechnology can be beneficial overall in one context and problematic in another.
  • Good synthesis compares, weighs and qualifies.
  • Case-study evidence matters more than generic opinion language.

Apply

  • Build balanced extended responses.
  • Use multiple case studies in one answer.
  • Answer "affect biodiversity" rather than drifting into "improve production" only.
Scan these before reading
vocab
SynthesisCombining multiple ideas and examples into one coherent judgement.
Evidence-based evaluationA judgement supported by relevant examples, conditions and limitations rather than absolute claims.
Trade-offA situation where a benefit is associated with a cost, risk or competing consequence.
Stakeholder impactHow different groups are affected differently by the same biotechnology.
Biodiversity effectThe effect of a biotechnology on genetic, species or ecosystem diversity.
Qualified judgementA conclusion using conditional language such as "to a large extent", "in some contexts" or "provided that".
Key Point
The top-band answer is not the most one-sided answer, and not a list of facts. It is the clearest answer about when, why and for whom a biotechnology is beneficial or problematic, ending in a qualified judgement.
1
A Strong Biotechnology Evaluation Uses a Repeatable Framework
+5 XP

Judgement structure · five moves in order

The Target Malaria consortium's 2019 Burkina Faso field trial of gene-drive-modified Anopheles mosquitoes offers a test case for evaluation: 247 million people got malaria in 2022, so the conservation value is massive. But gene drives spread at 100% efficiency, not the 50% Mendelian rate, meaning that once a gene drive is released, it propagates through a wild population and cannot be recalled. Communities in Burkina Faso who were not fully consulted about the 2019 release are among the most directly affected. A strong evaluation addresses all of this, not just the malaria statistic.

1. State the benefit

Identify the biological or social problem the technology may help solve.

2. State the risk or limitation

Identify welfare, environmental, ownership, access or uncertainty issues.

3. Identify stakeholders

Explain who benefits, who carries risk and whether the distribution is fair.

4. Include biodiversity

Explain whether genetic, species or ecosystem diversity is supported or reduced.

5. Conclude conditionally

Judge to what extent the benefit outweighs the risk, and under what conditions.

A complete biotechnology evaluation uses five moves: identify the benefit, describe the risk or limitation, analyse stakeholder impact, assess the biodiversity effect at a named level, and reach a conditional conclusion, the strongest answers are conditional, not one-sided.

Pause, copy the highlighted framework into your book before moving on.

Which feature is most important in a strong synthesis answer about biotechnology?

2
Different Biotechnology Cases Often Produce Different Balances of Benefit and Risk
+5 XP

Case comparison · medicine vs agriculture vs animals

We just saw that a five-move framework structures strong evaluations. That raises a question: how do those moves play out differently across medical, agricultural and animal cases? This card answers it → case-specific evaluation dimensions.

Medical biotechnology case

  • Can offer major health benefits, such as better diagnosis or biological medicine production.
  • Main evaluation issues: access, cost, safety, consent and fairness.

Agricultural biotechnology case

  • Can improve yield, resistance or efficiency.
  • Main evaluation issues: ownership, monoculture risk, farmer dependence and biodiversity trade-offs.

Animal biotechnology case

  • Can support production or medical research.
  • Main evaluation issues: welfare, necessity, harm and ethical justification.

Because the balance differs across cases, synthesis answers should compare cases rather than forcing one universal conclusion too early.

Case Set
A high-quality module response might compare engineered insulin production, crop-biotechnology systems and conservation-genetics programs. That lets the student show that "benefit" looks different in medicine, agriculture and biodiversity management.

Medical biotechnology raises access, cost, safety and consent issues; agricultural biotechnology raises ownership, monoculture and biodiversity trade-offs; animal biotechnology raises welfare, necessity and harm issues, compare cases rather than forcing one universal conclusion.

Add the highlighted point to your notes before the check below.

Why is comparing multiple case studies useful in biotechnology evaluation?

3
When the Question Is About Biodiversity, Productivity Alone Is Not Enough
+5 XP

Keep the question on track · answer what is asked

We just saw that different case studies raise different evaluation issues. That raises a question: what does a poorly-written evaluation miss compared to a strong one? This card answers it → what to include and what to avoid.

Many weak responses drift into "this crop gives better yield" and stop there. That may be true, but the biodiversity question asks something more specific. Students must explain whether diversity at genetic, species or ecosystem level is preserved, reduced or changed in mixed ways.

Weak response

  • "Biotechnology is good because it increases production."
  • No biodiversity level identified.
  • No risk, stakeholder or trade-off analysis.

Strong response

  • Identifies benefit and biodiversity level.
  • Explains whether diversity is supported or reduced.
  • Includes conditions, risks and stakeholder impact.

A strong evaluation explicitly names the biodiversity level affected, states whether diversity is preserved or reduced, and adds conditions, risks and stakeholder impact, "biotechnology is good because it increases production" is a poor answer because it confuses productivity with biodiversity.

Pause, write the highlighted distinction into your book.

"This crop gives a better yield" fully answers a question about the biodiversity effect of a biotechnology.

Evaluating biotechnology requires balancing potential benefits against risks to human health, the environment, and biodiversity.

The risks of biotechnology can be fully predicted before any field trials are conducted.

4
The Best Final Judgement Is Qualified, Comparative and Evidence-Led
+5 XP

Conclusion skill · how to land the answer

We just saw that good evaluation names the biodiversity level and conditions. That raises a question: how should a final evaluative conclusion be written? This card answers it → conditional judgement language.

Good synthesis does not end with "there are pros and cons". It ends with a reasoned judgement. That judgement should be comparative and conditional. For example:

Stronger style

  • "To a large extent, biotechnology benefits society in medicine, provided access and safety are well managed."
  • "In agriculture, benefits may be substantial, but biodiversity trade-offs can reduce the overall value if diversity is narrowed too far."

This lesson is the final preparation for the checkpoint. Students should now be able to integrate the entire biotechnology inquiry question into one coherent answer.

Strong evaluative conclusions are comparative and conditional, use phrases such as "to a large extent", "provided that" and "in this context" to reach a qualified judgement rather than ending with "there are pros and cons" without a final position.

Pause, copy the highlighted language pattern into your notes before continuing.

A conclusion using conditional language such as "to a large extent" or "provided that" is called a _____ judgement.

Activity 1
AnalyseBand 4

Build the Paragraph

Pick one biotechnology case and write four sentences using this order:

  1. Main benefit.
  2. Main risk or trade-off.
  3. Biodiversity or stakeholder impact.
  4. Final qualified judgement.
Activity 2
AnalyseBand 4

Compare Two Cases

Compare a medical biotechnology case with an agricultural biotechnology case. Explain why the balance of benefit and risk is not identical in both cases.

Cross-lesson links: L09–L11 evaluated individual biotechnologies. L12 consolidates IQ2 by examining a technology (gene drives) that crosses multiple evaluation criteria simultaneously, conservation value, ecological risk, ethical consent of affected communities, and irreversibility. Apply your full L09–L11 framework here.
PRIORITY MISCONCEPTIONS
Priority Misconceptions
✗ A thorough HSC response on biotechnology just lists all the relevant facts.
✓ High-scoring extended responses analyse evidence, identify trade-offs and limitations, consider multiple stakeholder perspectives, and reach a supported judgement, not a catalogue of information. Synthesis and evaluation, not recall, earn the top marks.

Core biological claim

  • Biotechnology should be evaluated through benefit, risk, biodiversity effect and stakeholder impact together.

Mechanism or process

  • A strong synthesis response compares case studies, weighs trade-offs and ends with a qualified judgement.

Common exam error

  • Listing benefits only, or discussing productivity without answering the biodiversity part of the question.

Evaluative sentence starter

  • "To a large extent, the biotechnology is beneficial in this context, but its overall value depends on stakeholder impact, biodiversity trade-offs and whether the benefits are distributed fairly."
Interactive Tool, Gene Pools & Biotechnology Open fullscreen ↗
Two of these statements about gene pools are TRUE. Find the LIE.
01
Multiple Choice
+5 XP

A fresh set drawn from this lesson's question bank, feedback shown immediately. +5 XP per correct · +25 XP all correct

Pick your answer, then rate your confidence, that tells the system what to drill next.

02
Short Answer, 12 marks
+5 XP

UnderstandBand 3(3 marks) 1. Outline a framework for evaluating biotechnology.

AnalyseBand 4(4 marks) 2. Explain why a strong answer about biotechnology should compare more than one case study.

EvaluateBand 5–6(5 marks) 3. Evaluate the statement: Biotechnology benefits society, so the main task is just to maximise its use.

Show all answers

Multiple choice

MC answers and full explanations are shown inline as you complete each question. Use the retry button to attempt a fresh set from the lesson bank.

Activity 1, Build the paragraph

A strong paragraph should state the biotechnology benefit, identify a trade-off or limitation, explain biodiversity or stakeholder impact, and then end with a qualified judgement such as "to a large extent" or "provided that".

Activity 2, Compare two cases

A good comparison would explain that medical biotechnology may offer strong direct health benefits but raise issues of cost and access, while agricultural biotechnology may improve productivity but raise ownership and biodiversity trade-offs. The key is that the balance is not identical across cases.

Short Answer Model Responses

Q1 (3 marks): A strong framework for evaluating biotechnology includes identifying the benefit [1], identifying risks or limitations [1], and judging stakeholder and biodiversity effects before reaching a qualified conclusion [1].

Q2 (4 marks): More than one case study is useful because different biotechnologies produce different balances of benefit and risk [1]. A medical case may emphasise health and access, while an agricultural case may emphasise productivity and biodiversity trade-offs [1]. Comparing cases makes evaluation more evidence-based and less one-sided [1]. Therefore multiple cases strengthen synthesis and lead to more accurate judgement [1].

Q3 (5 marks): The statement is incomplete because biotechnology may benefit society, but benefit alone does not justify maximising use without evaluation [1]. Biotechnology can improve medicine, productivity or conservation in some contexts [1]. However, it may also create trade-offs involving biodiversity, stakeholder fairness, ownership, welfare or access [1]. Therefore the key task is not simply maximisation, but careful evaluation of where and how biotechnology should be used [1]. Its value depends on whether benefits outweigh risks in the specific context [1].

RAPID REVIEW
The big ideas in four tiles

Strong synthesis

Benefit + risk + biodiversity + stakeholder impact + qualified judgement.

Case comparison

Different biotechnologies produce different trade-offs.

Biodiversity focus

Do not drift into productivity-only answers.

Exam trap

Ending with "there are pros and cons" instead of a reasoned conclusion.

Test yourself against the clock
boss

Rapid-fire questions synthesising benefit, risk, biodiversity and qualified judgement across IQ2. Beat the boss to bank a tier, gold (perfect + fast), silver (80%+), or bronze (cleared).

How did your thinking change?

Return to the Target Malaria gene drive case (Gates Foundation / first African release Burkina Faso 2019, 247 million malaria cases in 2022 per WHO). You should now be able to build a structured evaluation: acknowledge the massive public health benefit (humanitarian value); note the ecological risk (mosquitoes are part of food chains, and suppression could affect insectivorous predators); identify the irreversibility problem (100% spread rate cannot be recalled from wild populations); and centre the consent issue (local communities not meaningfully consulted for the 2019 trial). A strong HSC response uses these categories, not a list of isolated advantages.